Pressure BioSciences Inc. PBIO Archives - Page 7 of 22

MondayFeb 08, 2021 1:08 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Acquire Assets of International Agrochemical Developer and Supplier

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform technology solutions to the worldwide biotechnology, biotherapeutics and other industries, today announced its entry into a letter of intent to purchase the assets of an internationally based developer and supplier of organically natural, eco-friendly agrochemicals. The company offers sought-after alternatives to synthetic pesticides and fertilizers serving rapidly growing global sectors of organic and environmentally-sustainable agricultural production. "Upon completion, this acquisition of assets will bring into PBI an established portfolio of respected brand names in the eco-friendly agrochemicals market, with unique…

WednesdayJan 20, 2021 10:46 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Collaboration to Evaluate Feasibility of Ultra Shear Technology Platform to Improve Effectiveness of SinuSys Lead Product Candidate

Pressure BioSciences (OTCQB: PBIO), today announced a collaboration with SinuSys Corporation aimed at evauating the potential for PBI's innovative Ultra Shear Technology(TM) ("UST") platform to strengthen the effectiveness of SinuSys Corp's lead product candidate Restora. Depending on the outcome of the collaboration, SinuSys plans to license PBI's UST platform for use with Restora on its path to FDA approval in a phase IIb clinical study later this year. PBIO is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform technology services to the worldwide biotechnology, biotherapeutics and other industries. SinuSys Corporation is a medical device…

ThursdayDec 17, 2020 10:48 am

QualityStocksNewsBreaks – Pressure BioSciences Inc.’s (PBIO) PCT Platform Selected as ‘Method of Choice’ for Many Global Research Teams

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of pressure-based instruments, consumables and platform solutions to the worldwide biotechnology and other industries, today announced a remarkable convergence of global research teams declaring pivotal new insights into COVID-19 biology and disease processes. According to the update, all teams selected PBI's Pressure Cycling Technology ("PCT") platform for critical sample preparation steps to help ensure that the greatest abundance and diversity of reproducible results would be revealed in the thousands of proteins involved in affected biochemical pathways. "The compelling history of scientists worldwide publishing on PBI's PCT-based Barocycler system…

TuesdayDec 15, 2020 12:47 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Slated to Present at Leading Investor Forum

Pressure BioSciences (OTCQB: PBIO) has announced that it will be presenting at the upcoming Life Sciences Investor Forum ("LSIF"). The leading proprietary investor conference is scheduled for Dec. 17, 2020, and is a live, interactive investor event held quarterly for public and private companies, investors and industry professionals from around the world. The daylong event features company presentations and interactive discussions about the life sciences sector. Pressure BioSciences president and CEO Richard T. Schumacher will be presenting at the forum. His presentation is scheduled for 11 a.m. ET and may include key highlights regarding the company’s three key technology platforms: Pressure Cycling…

WednesdayDec 09, 2020 2:49 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) on Track to Launch BaroShear K45 Nanoemulsification System in 2021

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative solutions for the worldwide life science and other industries, recently reported its third-quarter financial results and provided a business update, which included initial expectations for 2021 (https://ibn.fm/8PNFi). Among the updates, the Q3 2020 Form 10-Q financial report outlines measurable progress in three important areas: key operational and technical projects; revenue increases in the company’s products and services offerings; and important structuring improvements in the reduction of arduous, variable-rate convertible debt. A recent article discussing this reads, “Providing other updates and plans for 2021, the Form 10-Q report also mentioned that Pressure…

FridayDec 04, 2020 10:31 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Commercial Launch Date for ImmunaZin(TM)

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of pressure-based instruments, consumables and platform solutions to the worldwide biotechnology and other industries, today announced that its proposed acquisition partner Cannaworx Inc. has set December 2020 as the commercial launch date for its patented immune booster supplement: ImmunaZin(TM). According to the update, Cannaworx believes that post-launch, this product will be one of very few over-the-counter, FDA-registered, hemp seed oil-enhanced supplements with an immune-booster claim. “Our team is excited to be joining a company bringing such an important and valuable product to market, particularly considering its potential role in…

WednesdayDec 02, 2020 12:30 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Looks to Provide Key to Commercial Success of Novel Products

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a developer of innovative solutions for the worldwide life science and other industries, recently secured its first U.S. patent for its innovative Ultra Shear Technology (“UST”) platform. Utilizing ultra-high pressure and intense shearing forces, the platform creates unique, high-quality nanoemulsions that have enormous use in a wide variety of industries. Pressure BioSciences has received pre-orders for 12 BaroShear K45 systems, which it plans to deliver during the first half of 2021, and is also is in discussions with academic organizations and government agencies expressing interest in the platform for other product and research possibilities. These…

TuesdayNov 24, 2020 11:30 am

Pressure BioSciences, Inc. (PBIO) Reports Revenue Hike in Q3, While Achieving Its Best Financial Quarter in Two Years; Company Expects Strong 2021

Measurable success achieved in Q3 2020 in key financial, operational, and technical projects Revenue increases reported in products and services offerings; balance sheet improved with significant reduction in variable-rate debt Q3 total revenue exceeded Q1 and Q2 total revenue combined Company reported receipt of 12 pre-orders for the innovative BaroShear K45, which is on track to be released in mid-2021 Alliance with Leica Microsystems over PBI’s proprietary pressure cycling technology (“PCT”) platform has the potential to accelerate cancer R&D and subsequent drug development using an innovative tumor processing workflow Pressure BioSciences (OTCQB: PBIO) is a leader in the development, marketing,…

WednesdayNov 18, 2020 10:02 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Q3 2020 Financial Results, Provides Business Update

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of pressure-based instruments, consumables and platform solutions to the worldwide life sciences and other industries, on Tuesday released financial results for the third quarter ended September 30, 2020. In addition, the company provided a business update and offered limited guidance for fiscal year 2021. “We are delighted with the results of the third quarter 2020, particularly in the measurable progress made in three important areas: (i) key operational and technical projects . . . ; (ii) revenue increases in our products and services offerings; and (iii) important restructuring…

TuesdayNov 17, 2020 10:24 am

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) to Host Conference Call to Discuss Q3 Finances, Business Update

Pressure BioSciences (OTCQB: PBIO) has scheduled a teleconference for today to release its third-quarter 2020 financial results and announce key business updates. PBIO is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics and other industries. The call, scheduled for today, Nov. 17, at 4:30 p.m. ET., will include a presentation followed by a Q&A session. Anyone in North America who is interested may attend the teleconference live by calling 877-407-8033 and using the verbal passcode PBI Third Quarter 2020 Financial Call and Business Update. Those living…

Site Search

Company Search

Tag: Pressure BioSciences Inc. PBIO